Full Text View
Tabular View
No Study Results Posted
Related Studies
Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture
This study is enrolling participants by invitation only.
First Received: March 24, 2008   Last Updated: March 25, 2008   History of Changes
Sponsored by: State University of New York - Upstate Medical University
Information provided by: State University of New York - Upstate Medical University
ClinicalTrials.gov Identifier: NCT00643175
  Purpose

Osteoporosis has been called a "silent epidemic" whose prevalence is increasing. It often presents as a fragility fracture, with hospitalizations resulting from minimally traumatic hip fractures. While the fractures are treated appropriately, the underlying pathology is often ignored. Numerous studies have shown that prior fracture increases the risk for further fracture. In 2004 the Surgeon General released a report on osteoporosis, the details of which include multi-disciplinary treatment of osteoporotic fractures. Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Possible planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.


Condition Intervention
Osteoporosis
Behavioral: Automated follow up

MedlinePlus related topics: Fractures Hip Injuries and Disorders Hip Replacement Osteoporosis
U.S. FDA Resources
Study Type: Observational
Study Design: Case-Only, Prospective

Further study details as provided by State University of New York - Upstate Medical University:

Estimated Enrollment: 20
Study Start Date: June 2007
Estimated Study Completion Date: June 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Osteoporosis in patients with fragility hip fractures.
Behavioral: Automated follow up
Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.

  Eligibility

Ages Eligible for Study:   55 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Using the existing WebCAIS order system, an automated endocrinology consult and appropriate laboratory studies will be drawn on all non-traumatic hip fractures. Data from these patients will be collected in a prospective study, and the patients will be followed up over time to check adherence to osteoporotic medical therapy and future incidence of re-fracture.

Criteria

Inclusion:

  1. over 55
  2. non-traumatic hip fracture

Exclusion criteria:

  1. currently on anti-osteoporosis pharmacotherapy including bisphosphonates, PTH, and calcitonin
  2. high energy nature of fracture, including MVA, fall from height greater than 3 feet
  3. severe dementia, lack of capacity
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00643175

Locations
United States, New York
SUNY Upstate Medical University
Syracuse, New York, United States, 13202
Sponsors and Collaborators
State University of New York - Upstate Medical University
  More Information

No publications provided

Responsible Party: SUNY Upstate Medical University ( Andrew Grose, MD )
Study ID Numbers: osteoporotic hip fracture
Study First Received: March 24, 2008
Last Updated: March 25, 2008
ClinicalTrials.gov Identifier: NCT00643175     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by State University of New York - Upstate Medical University:
The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.

Study placed in the following topic categories:
Hip Fractures
Musculoskeletal Diseases
Fractures, Bone
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

Additional relevant MeSH terms:
Musculoskeletal Diseases
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases

ClinicalTrials.gov processed this record on May 07, 2009